Expert consensus predicts integration of CTC testing into routine clinical practice within 5 years 2. CTCs provide distinct and impactful information that is not captured by circulating tumour DNA ...
The approval was based on data from a Phase II trial, two retrospective chart review studies and an expanded access programme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback